Recombinant Human FLT3 Ligand Protein Dry Baths Traditional RAS pathway inhibitors often

Traditional RAS pathway inhibitors often fail because they only target inactive GDP-bound states or specific single mutations

it rapidly accelerates to a maximum speed of 15

1 μL to 10 mL depending on model selection

1 mg lyophilized product — so you dose by biological activity

applications in scientific experiments

Recombinant Human FLT3 Ligand Protein Dry Baths Traditional RAS pathway inhibitors oftenDescription The recombinant human Fms Related Tyrosine Kinase 3 Ligand (FLT3L Flt3 Ligand) is a high purity, four helical bundle cytokine produced in HEK 293 expression systems, typically existing as a noncovalently linked dimer. As a pivotal cytokine in the hematopoietic system, FLT3L specifically binds to its receptor FLT3 (CD135 FLK 2 STK 1, a class III receptor tyrosine kinase), activating downstream signaling pathways including RAS MAPK and PI3K